<DOC>
	<DOCNO>NCT00500708</DOCNO>
	<brief_summary>Heart failure ( HF ) affect 5 million Americans , 500,000 new case diagnose 250,000 death year . The two major cause morbidity mortality HF pump failure sudden , lethal ventricular arrhythmia , latter account 40-50 % HF death . Arrhythmias may precipitate complex interaction genetic environmental factor . Establishing increased risk arrhythmia severe life-threatening event critically important . However , remain significant medical challenge . Several genetic mutation associate rare , inherited arrhythmia disorder identify . The aim study identify novel genetic biological marker distinguish patient increase risk lethal ventricular arrhythmia broad population .</brief_summary>
	<brief_title>Diagnostic Investigation Sudden Cardiac Event Risk</brief_title>
	<detailed_description />
	<criteria>Implantable cardiac defibrilIator ( ICD ) cardiac resynchronization therapy defibrillator ( CRTD ) implant primary prevention Left ventricular ejection fraction ( LVEF ) â‰¤ 50 % Ability collect clinical followup endpoint information , include device interrogation data Congenital heart disease Known inherit arrhythmia disorder Organ transplantation Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Implanted Cardioverter Defibrillator</keyword>
	<keyword>Biological Markers</keyword>
	<keyword>Molecular Genetics</keyword>
</DOC>